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HIV clinical stage progression of patients at 241
outpatient clinics in Democratic Republic of
Congo: Disparities by gender, TB status and
rurality

A rare case of supratentorial hemangioblastoma
in HIV/AIDS patient with multiple opportunistic
infections
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Background: HIV clinical care programs are increasingly cognizant of the importance of customizing services according to
patients’ clinical stage progression (WHO’s four-tiered staging) and
other risk assessments. Understanding factors associated with Persons Living with HIV (PLHIV) patients’ progression through the
treatment cascade and clinical stages is essential for programs to
provide patient-centered, evidence-based services.
Methods and materials: To analyze patient characteristics
associated with disease progression stages for PLHIV on antiretroviral therapy (ART), this quantitative study used data, from January
2014–June 2019, from 49,460 PLHIV on ART from 241 HIV/AIDS
outpatient clinics in 23 health zones in Haut-Katanga and Kinshasa
provinces, Democratic Republic of Congo. To assess bivariate and
multivariate associations, we performed Chi-square and multinomial logistic regression.
Results: Among PLHIV receiving ART, 4.4% were at stage 4, and
30.7% at stage 3. Those at the less severe stages 2 and 1 constituted
22.9% and 41.9%. After controlling for covariates, patients with no
TB were signiﬁcantly more likely than those with TB (p< = .05) to
be at stage 1, rather than 3 or 4 (adjusted odds ratio or AOR, 5.73;
conﬁdence interval or CI, 4.98–6.59). Other characteristics significantly associated with higher odds of being at stage 1 included
being female (AOR, 1.35; CI, 1.29–1.42), and shorter duration on
ART (vs. > 40.37 months); for ART duration less than 3.23 months
the AOR was 2.47, for 3.23–14.52 months duration the AOR was
2.60, and for 14.53–40.37 months duration the AOR was 1.77 (quartile cut points used). Compared to patients in urban health zones,
those in rural (AOR, 0.32) and semi-rural health zones (AOR, 0.79)
were less likely to be at stage 1.
Conclusion: Signiﬁcant and substantial variation in HIV clinical
progression stage by geographic location and demographic characteristics existed, indicative of the need for targeted efforts to
improve the effectiveness of HIV care. Patients with TB coinfection
compared to those without coinfection had a much greater risk of
being at stage 3 or 4, implying a need for customized approaches
and clinical regimens for this high-risk population.
https://doi.org/10.1016/j.ijid.2020.09.768
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Background: An opportunistic infection was a deathly problem in HIV/AIDS. A patient with a CD4 count below 200 cells/L
poses a high risk to suffer from multiple opportunistic infections.
Moreover, several studies have shown that HIV/AIDS can induce
malignancy. Here we report an HIV patient with multiple opportunistic infections and supratentorial hemangioblastoma.
Case description: A 33-year-old housewife with known HIV
positive status, suspected of being transmitted with HIV by her
husband who had died in 2014. Since then, she took antiretroviral drugs for 3 months and stopped it by herself until now. She
was admitted to the hospital in lethargic condition with severe
headaches, nausea, vomiting, difﬁculty to swallow and one-time
seizure. Physical examination showed decreased vision of the right
eye, oral thrush, crackles in both lung apices, and signs of moderate
mild dehydration. Laboratory results were microcytic hypochromic
anemia, hyponatremia, hypokalemia, hypocalcemia, and hypoalbuminemia. The CD4 counts were 4 cells/L, and Reactive IgG and
IgM for Cytomegalovirus. The X-ray and CT scan of thorax indicated
active pulmonary tuberculosis infection. Funduscopic examination showed a cotton wool spot, a typical sign of Cytomegalovirus
retinitis. The contrast-enhanced MRI of the brain revealed a suggestive image of supratentorial hemangioblastoma. The patient was
treated with lamivudine, tenofovir, and efavirenz as antiretroviral drugs; rifampicin, isoniazid, pyrazinamide, and ethambutol as
antituberculosis drugs; intravenous ganciclovir; intravenous ﬂuconazole; nutritional therapy and was planned for craniotomy,
unfortunately, the patient refused surgery.
Discussion: Supratentorial hemangioblastoma, a rare type of
tumor that counts only 1–2% of all hemangioblastomas, and 8–12%
of all types of intracranial neoplasms. The cause of this malignancy
in this patient is unknown. A very low CD4 evoked multiple infections complicating the patient.
Conclusion: Adherence to treatment is an important key to prevent the manifestation of various opportunistic infections and even
malignancy in HIV patients. Proper holistic treatment is needed to
improve the patient’s condition.
https://doi.org/10.1016/j.ijid.2020.09.769

